M. Risch

Discipline

Sociologie (1)

Type de document

Articles (6)

Co-auteur

Date

Source

Mot-clé

analyse (4) Patients (4) Analysis (4) Patients (4) thérapie (3) Development (3) Treatment (3) Therapeutics (3) Older people (3) risque (2) santé publique (2) association (2) âge (2) biomarqueur (2) survie (2) Inhibitors (2) Ci (Chinese poetry) (2) Swiss (2) Survival (2) Social groups (2) Serum (2) Risk (2) Public health (2) Melanoma (2) Manufacturers' agents (2) Human beings (2) Laboratories (2) Impact (2) Evaluation (2) Commission merchants (2)

Documents écrit par M. Risch (6) | parle de M. Risch (0)

IVDR: Analysis of the Social, Economic, and Practical Consequences of the Application of an Ordinance of the In Vitro Diagnostic Ordinance in Switzerland.
A.T. Coste et al. (11 sept. 2023)
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
M.T. Purde et al.
SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing.
A.R. Goncalves Cabecinhas et al. (25 mars 2021)
Treatment of urinary tract infections in Swiss primary care: quality and determinants of antibiotic prescribing.
A. Plate et al. (1 juil. 2020)
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients.
M. Fässler et al. (20 févr. 2019)
Association of smoking and nicotine dependence with pre-diabetes in young and healthy adults.
S. Aeschbacher et al. (2014)